Uscom Limited released its earnings results on Feb 07, 2024. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.

Q: Is Uscom Limited overvalued?

According to Wall Street analysts Uscom Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Uscom Limited have?

Uscom Limited has 244,587,620 shares outstanding.

Q: What happened to Uscom Limited’s price movement after its last earnings report?

Uscom Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

0 Followers

UCM Stock Chart & Stats

Advanced Chart >

Day’s RangeAU$0 - AU$0

52-Week Range<AU$0.01 - AU$0.13

Previous CloseAU$0.02

Volume43.60K

Average Volume (3M)99.22K

Market Cap

AU$5.87M

Enterprise ValueAU$2.48M

Total Cash (Recent Filing)AU$4.70M

Total Debt (Recent Filing)AU$1.31M

Price to Earnings (P/E)-2.2

Beta-0.21

Next Earnings

Aug 15, 2024

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding244,587,610

10 Day Avg. Volume124,143

30 Day Avg. Volume99,217

Standard Deviation0.24

R-Squared0.01

Alpha0.02

Financial Highlights & Ratios

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Uscom Limited News

PremiumCompany Announcements

Uscom Limited Reports Strong Q3 Financial Growth

22d ago

UCM

See More AU:UCM News >

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

58.82% Insiders

0.00% Mutual Funds

0.00% Other Institutional Investors

41.18% Public Companies and

Individual Investors

Detailed Ownership Overview >

UCM FAQ

What was Uscom Limited’s price range in the past 12 months?

Uscom Limited lowest share price was <AU$0.01 and its highest was AU$0.13 in the past 12 months.

What is Uscom Limited’s market cap?

Currently, no data Available

When is Uscom Limited’s upcoming earnings report date?

Uscom Limited’s upcoming earnings report date is Aug 15, 2024 which is in 91 days.

How were Uscom Limited’s earnings last quarter?

Uscom Limited released its earnings results on Feb 07, 2024. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.

Is Uscom Limited overvalued?

According to Wall Street analysts Uscom Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Uscom Limited pay dividends?

Uscom Limited does not currently pay dividends.

What is Uscom Limited’s EPS estimate?

Uscom Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Uscom Limited have?

Uscom Limited has 244,587,620 shares outstanding.

What happened to Uscom Limited’s price movement after its last earnings report?

Uscom Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Uscom Limited?

Currently, no hedge funds are holding shares in AU:UCM

---

Uscom Limited Stock Smart Score

Neutral

Insider Transactions

Bought Shares

Worth AU$1.6M over
the Last 3 Months

Technicals

Fundamentals

Return on Equity

-61.60%

Trailing 12-Months

Asset Growth

-8.27%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Uscom Limited

USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Asia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimising respiratory device performance.

---